Skip to main content
BIOXYNE LIMITED logo

BIOXYNE LIMITED — Investor Relations & Filings

Ticker · BXN ISIN · AU000000BXN6 LEI · 984500F02D2B1B94E956 ASX Manufacturing
Open in API
Filings indexed 844 across all filing types
Latest filing 2011-11-29 Capital/Financing Update
Country AU Australia
Listing ASX BXN

About BIOXYNE LIMITED

https://bioxyne.com

Bioxyne Limited is a life sciences company focused on the development, manufacture, and commercialization of health and wellness products. The company specializes in proprietary probiotic strains, notably the Lactobacillus fermentum VRI-003 (PCC), which is utilized in supplements targeting immune health and gut function. Following the acquisition of Breathe Life Sciences, Bioxyne has expanded its portfolio into the medicinal cannabis sector, novel foods, and consumer health products. Its operations encompass the production and distribution of pharmaceutical-grade cannabis products, CBD-based wellness items, and functional supplements. The company serves international markets through a vertically integrated model, focusing on research-driven formulations and high-quality manufacturing standards to address growing consumer demand for therapeutic and preventative health solutions.

Recent filings

Filing Released Lang Actions
Section 708 A (6) Notice and Appendix 3B 8 pages 266.4KB
Capital/Financing Update Classification · 100% confidence The document is a notice from Probiomics Limited to the Australian Securities Exchange (ASX) announcing the completion of a private placement of shares. It includes a Section 708A(6) notice under the Corporations Act 2001 (Cth), which relates to the issue of securities without disclosure under Part 6D.2 of the Act. The document also contains an Appendix 3B, which is a standard ASX form for new issue announcements, application for quotation of additional securities, and related agreements. The content focuses on the issuance of new shares, placement details, fees, and the application for quotation of these securities on the ASX. There are no financial statements, management discussion, or earnings data present. The document is regulatory in nature, announcing a capital raising event and compliance with disclosure requirements. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2011-11-29 English
Chairman`s Address to Shareholders 3 pages 49.8KB
AGM Information Classification · 95% confidence The document is titled 'Chairman’s AGM Speech' and is dated 29 November 2011. It is addressed to attendees of the Annual General Meeting (AGM) and includes a summary of the financial year, recent developments, and future outlook. The content is a speech delivered at the AGM rather than a full annual report or financial statements. It discusses company operations, merger proposals, and strategic direction, typical of AGM presentations. The document length is about 5103 characters, which is consistent with a speech or presentation rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2011-11-28 English
Results of Meeting 2 pages 46.0KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'RESULTS OF ANNUAL GENERAL MEETING RESOLUTIONS' and dated 29 November 2011. It reports the voting outcomes on resolutions at the AGM, including election of a director and remuneration policy approval. The text provides detailed vote counts for each resolution. There is no financial data or detailed report content, only the official announcement of voting results. The document length is short (1681 characters), consistent with a voting results announcement rather than a full AGM report or presentation. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2011-11-28 English
Placement 2 pages 145.8KB
Capital/Financing Update Classification · 95% confidence The document is a short announcement dated 3rd November 2011 from Probiomics Limited regarding a private placement of shares to raise $200,000. It details the number of shares issued, the price per share, the purpose of the funds, underwriting information, and references the Corporations Act. There are no financial statements, detailed financial analysis, or comprehensive report content. The document is under 5,000 characters and serves as a notification of a capital raising event through a private placement. This fits the definition of a Capital/Financing Update (CAP) rather than a full financial report or other categories.
2011-11-02 English
Termination of Agreement with Nestec 2 pages 146.4KB
Regulatory Filings Classification · 95% confidence The document is a short announcement dated 2nd November 2011 from Probiomics Limited regarding the termination of a Development & Licence Agreement with Nestec SA. It includes statements from the Chairman and plans for future alliances related to a merger. There are no financial statements, detailed financial data, or regulatory form references. The document is brief (1742 characters) and serves as a corporate announcement about a contract termination and strategic direction, not a financial report or detailed regulatory filing. Therefore, it fits best as a Regulatory Filing (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2011-11-01 English
Appendix 4C - quarterly 5 pages 145.8KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Appendix 4C Quarterly report for entities admitted on the basis of commitments' and contains detailed quarterly financial data including consolidated cash flow statements, cash reconciliation, and notes on compliance with accounting standards. The presence of quarterly financial data and the nature of the report align with a comprehensive financial report for a period shorter than a full fiscal year. The document length is 6925 characters, which is sufficient to contain substantive financial data rather than just an announcement. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2011
2011-10-24 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.